Therapeutic drug monitoring of imatinib in patients with gastrointestinal stromal tumours – Results from daily clinical practice-Reference-Cited by-同舟云学术

Therapeutic drug monitoring of imatinib in patients with gastrointestinal stromal tumours – Results from daily clinical practice

Published:2020-09 Issue: Volume:136 Page:140-148
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

IJzerman Nikki S.^ORCID,Groenland Stefanie L.,Koenen Anne Miek,Kerst Martijn,van der Graaf Winette T.A.,Rosing Hilde,Beijnen Jos H.,Huitema Alwin D.R.,Steeghs Neeltje

Funder

GIST

Novartis

Pfizer

Bayer

Deciphera

Astex

PharmaMar

Roche

AB Science

Abbvie

Actuate Therapeutics

Amgen

Array

AstraZeneca

MedImmune

Blueprint Medicines

Boehringer Ingelheim

Bristol-Myers Squibb

Cantargia

Cytovation

Genentech

GlaxoSmithKline

Incyte

InteRNA

Lilly

Merck Sharp & Dohme

Merus

Pierre Fabre

Sanofi

Takeda

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor;Güller;BMC Canc,2015

2. Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors;Demetri;J Clin Oncol,2009

3. Plasma exposure of imatinib and its correlation with clinical response in the tyrosine kinase inhibitor optimization and selectivity trial;Guilhot;Haematologica,2012

4. Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study;Larson;Blood,2008

5. Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia;Picard;Blood,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study;British Journal of Cancer;2024-07-06

2. Advanced gastrointestinal stromal tumor: reliable classification of imatinib plasma trough concentration via machine learning;BMC Cancer;2024-02-24

3. Correlation Between N-Demethyl Imatinib Trough Concentration and Serious Adverse Reactions in Patients with Gastrointestinal Stromal Tumors: A Retrospective Cohort Study;Therapeutic Drug Monitoring;2024-01-04

4. Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 Patients;Drugs & Aging;2023-12-20

5. Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation;Pharmacogenomics;2023-12